GRP093 Table 2
Number of interventions/year
Reasons for intervenning20092010Recommendations
Hb increases more than 2 g/dl in 4 weeks91Changing dose or frequency of ESF administration
Hb>12298
Hb≥1303Discontinuing drug, for safety
Hb<11 to high doses*348Discontinuing, inefficiency
Beginnings treatment Hb>1004Not beginning
  • * Epoetin α doses>300 units/kg/week or darbepoetin α>1, 5 εg/kg/week.

  • Hb levels (g/dl).